News
Nexplanon UPDATE from Dispex!!
By Dr Philip Koopowitz – Dispex & Hexagon6 Following clarification from NHSBSA, the reclassification of Nexplanon as “Attracts an Administration Fee” only comes into force on 1st January 2025. I would like...
UPDATE: Class 3 Medicines Recall: Glenmark Pharmaceuticals Europe Ltd Cyanocobalamin 50 mcg Tablets, EL(24)A/46
Source: MHRA/Gov.uk 24.10.24 Glenmark Pharmaceuticals Europe Ltd is recalling the affected batches as a precautionary measure due to out of specification results for unknown impurities during routine stability testing and...
Class 2 Medicines Recall: Bristol Laboratories Ltd, Phenobarbital Bristol Labs 15mg Tablets, EL(24)A/50
Source: MHRA/Gov.uk 23.10.24 Bristol Laboratories Ltd. are recalling one batch of Phenobarbital Bristol Labs 15mg Tablets as a precautionary measure due to the potential of contamination of small metallic particles...
SAVE THE DATE – Dispex Live II
Exciting News! Our Webinar is Back by Popular Demand! Get ready for another session with Dispex, this time on Wednesday, 26th February 2025, from 1-2 PM. Join industry experts Philip...
Class 4 Medicines Defect Information: Kent Pharma UK, Paracetamol 500mg Effervescent Tablets, EL(24)A/49
Source: MHRA/ Gov.uk 21.10.24 DMRC reference number DMRC-32772688 Company name Kent Pharma UK Paracetamol 500mg Effervescent x100 Tablets (P), PL 51463/0031 SNOMED Codes 1856211000001101 (5×20) 1856011000001106 (10×10) Paracetamol 500mg Effervescent...
GPCE vision: What do Practice Managers think?
Source: Practice Index The British Medical Association’s General Practitioners Committee (GPC) has outlined a vision to address the ongoing crisis in general practice. Their Patients First proposal seeks immediate reforms to prevent...
Dispex Launches Dispex AI
Your Dispensing- Friendly Chatbot Dispex is excited to unveil its latest innovation, Dispex AI, an intelligent and user-friendly chatbot designed to assist dispensing teams with all their queries. From complex...
CQC responds to reviews by Dr Penny Dash and Professor Sir Mike Richards
Source: The CQC 15.10.24 The Care Quality Commission (CQC) has welcomed 2 important reviews that will help to set the future direction for CQC: the final report of Dr Penny...
Dispensary Formulary for Laxatives
By Dr Philip Koopowitz – Dispex & Hexagon6 When was the last time you considered your Dispensary Formulary for Laxatives? You may be leaking money by prescribing and dispensing certain...
Category M Prices October 2024 – another kick in the teeth for dispensaries and pharmacies
By Dr Philip Koopowitz – Dispex & Hexagon6 There has been a further £9 million taken out of the pharmacy contract via a reduction in Category M prices. There are...
Good News for ALL Practices Nexplanon now Attracts an Administration Fee
UPDATE from Dispex 25th October 2024 By Dr Philip Koopowitz – Dispex & Hexagon6 Following clarification from NHSBSA, the reclassification of Nexplanon as “Attracts an Administration Fee” only comes into...
New Resources
PRINTED Copies Of The Dispensary Manager’s Guide At last month’s DDA conference, we presented the first printed copy, and delegates expressed a preference for being able to hold a physical version...
